Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis

Positive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AM...

Full description

Bibliographic Details
Main Authors: Kseniya N. Sedenkova, Denis V. Zverev, Anna A. Nazarova, Mstislav I. Lavrov, Eugene V. Radchenko, Yuri K. Grishin, Alexey V. Gabrel’yan, Vladimir L. Zamoyski, Vladimir V. Grigoriev, Elena B. Averina, Vladimir A. Palyulin
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/23/8252
_version_ 1797462625173372928
author Kseniya N. Sedenkova
Denis V. Zverev
Anna A. Nazarova
Mstislav I. Lavrov
Eugene V. Radchenko
Yuri K. Grishin
Alexey V. Gabrel’yan
Vladimir L. Zamoyski
Vladimir V. Grigoriev
Elena B. Averina
Vladimir A. Palyulin
author_facet Kseniya N. Sedenkova
Denis V. Zverev
Anna A. Nazarova
Mstislav I. Lavrov
Eugene V. Radchenko
Yuri K. Grishin
Alexey V. Gabrel’yan
Vladimir L. Zamoyski
Vladimir V. Grigoriev
Elena B. Averina
Vladimir A. Palyulin
author_sort Kseniya N. Sedenkova
collection DOAJ
description Positive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AMPA receptor’s allosteric binding site. In the present work, novel bis(pyrimidines) were studied as AMPA receptor modulators. A convenient and flexible preparative approach to bis(pyrimidines) containing a hydroquinone linker was elaborated, and a series of derivatives with varied substituents was obtained. The compounds were examined in the patch clamp experiments for their influence on the kainate-induced currents, and 10 of them were found to have potentiating properties. The best potency was found for 2-methyl-4-(4-((2-methyl-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)phenoxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>d</i>]pyrimidine, which potentiated the kainate-induced currents by up to 77% in all tested concentrations (10<sup>−12</sup>–10<sup>−6</sup> M). The results were rationalized via the modeling of modulator complexes with the dimeric ligand binding domain of the GluA2 AMPA receptor, using molecular docking and molecular dynamics simulation. The prediction of ADMET, physicochemical, and PAINS properties of the studied bis(pyrimidines) confirmed that PAMs of this type may act as the potential lead compounds for the development of neuroprotective drugs.
first_indexed 2024-03-09T17:39:16Z
format Article
id doaj.art-0407b9018059428e84eb2f481bc3d013
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T17:39:16Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-0407b9018059428e84eb2f481bc3d0132023-11-24T11:39:07ZengMDPI AGMolecules1420-30492022-11-012723825210.3390/molecules27238252Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR AnalysisKseniya N. Sedenkova0Denis V. Zverev1Anna A. Nazarova2Mstislav I. Lavrov3Eugene V. Radchenko4Yuri K. Grishin5Alexey V. Gabrel’yan6Vladimir L. Zamoyski7Vladimir V. Grigoriev8Elena B. Averina9Vladimir A. Palyulin10Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Severny proezd 1, Chernogolovka, 142432 Moscow, RussiaInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Severny proezd 1, Chernogolovka, 142432 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, RussiaPositive allosteric modulators (PAMs) of AMPA receptors represent attractive candidates for the development of drugs for the treatment of cognitive and neurodegenerative disorders. Dimeric molecules have been reported to have an especially potent modulating effect, due to the U-shaped form of the AMPA receptor’s allosteric binding site. In the present work, novel bis(pyrimidines) were studied as AMPA receptor modulators. A convenient and flexible preparative approach to bis(pyrimidines) containing a hydroquinone linker was elaborated, and a series of derivatives with varied substituents was obtained. The compounds were examined in the patch clamp experiments for their influence on the kainate-induced currents, and 10 of them were found to have potentiating properties. The best potency was found for 2-methyl-4-(4-((2-methyl-5,6,7,8-tetrahydroquinazolin-4-yl)oxy)phenoxy)-6,7,8,9-tetrahydro-5<i>H</i>-cyclohepta[<i>d</i>]pyrimidine, which potentiated the kainate-induced currents by up to 77% in all tested concentrations (10<sup>−12</sup>–10<sup>−6</sup> M). The results were rationalized via the modeling of modulator complexes with the dimeric ligand binding domain of the GluA2 AMPA receptor, using molecular docking and molecular dynamics simulation. The prediction of ADMET, physicochemical, and PAINS properties of the studied bis(pyrimidines) confirmed that PAMs of this type may act as the potential lead compounds for the development of neuroprotective drugs.https://www.mdpi.com/1420-3049/27/23/8252pyrimidinesS<sub>N</sub>Ar reactionsbis(pyrimidine)bivalent ligandionotropic glutamate receptorsAMPA receptor
spellingShingle Kseniya N. Sedenkova
Denis V. Zverev
Anna A. Nazarova
Mstislav I. Lavrov
Eugene V. Radchenko
Yuri K. Grishin
Alexey V. Gabrel’yan
Vladimir L. Zamoyski
Vladimir V. Grigoriev
Elena B. Averina
Vladimir A. Palyulin
Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
Molecules
pyrimidines
S<sub>N</sub>Ar reactions
bis(pyrimidine)
bivalent ligand
ionotropic glutamate receptors
AMPA receptor
title Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
title_full Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
title_fullStr Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
title_full_unstemmed Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
title_short Novel Nanomolar Allosteric Modulators of AMPA Receptor of Bis(pyrimidine) Series: Synthesis, Biotesting and SAR Analysis
title_sort novel nanomolar allosteric modulators of ampa receptor of bis pyrimidine series synthesis biotesting and sar analysis
topic pyrimidines
S<sub>N</sub>Ar reactions
bis(pyrimidine)
bivalent ligand
ionotropic glutamate receptors
AMPA receptor
url https://www.mdpi.com/1420-3049/27/23/8252
work_keys_str_mv AT kseniyansedenkova novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT denisvzverev novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT annaanazarova novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT mstislavilavrov novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT eugenevradchenko novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT yurikgrishin novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT alexeyvgabrelyan novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT vladimirlzamoyski novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT vladimirvgrigoriev novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT elenabaverina novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis
AT vladimirapalyulin novelnanomolarallostericmodulatorsofampareceptorofbispyrimidineseriessynthesisbiotestingandsaranalysis